Metabolic medicines and addiction: what GLP-1 receptor agonists might add to substance use care Post date 4 March 2026 ← Medical news in brief: Illegal weight loss jab raid, new pill for sleeping sickness, healthcare attacks rise, and other stories → GLP-1 receptor agonists and risk of substance use disorders